Matthew J. Fenton, Ph.D., serves as director of the Division of Extramural Activities (DEA) at NIAID. Dr. Fenton oversees the management of grants, contracts, peer review, training and career development, Small Business Innovation Research programs, and extramural policies for the Institute. Under Dr. Fenton’s leadership, DEA performs the following specialized functions:
Dr. Fenton serves on several trans-National Institutes of Health extramural oversight groups and is a member of the NIAID Executive Committee.
Dr. Fenton joined NIAID as the chief of the Allergy, Asthma and Airway Biology Branch in the Division of Allergy, Immunology, and Transplantation in June 2005. In this role Dr. Fenton oversaw basic and clinical research programs in asthma, allergic diseases, and airway biology. Since joining NIAID, Dr. Fenton has led several high-impact projects, including an evaluation of the safety and efficacy of a novel pandemic (H1N1) influenza vaccine in people with severe asthma. Under his leadership, the Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of the NIAID-Sponsored Expert Panel was published in 2010. Development of the guidelines took two years and involved collaboration with more than 30 professional societies, federal agencies, and advocacy groups.
Before joining NIAID, Dr. Fenton was a Professor of Medicine, Immunology and Microbiology at the University of Maryland School of Medicine in Baltimore from 2003 to 2005, and a Professor of Medicine and Pathology at the Boston University School of Medicine from 1988 to 2003. His research focused on the role of innate immunity in inflammatory and bacterial infectious diseases.
Dr. Fenton has authored more than 100 peer-reviewed publications. He is a past Section Editor of the The Journal of Immunology, Past President of the International Cytokine Society, and Past President of the Society for Leukocyte Biology. In 2006, Dr. Fenton was elected a Fellow of the American Academy of Allergy, Asthma & Immunology.
Last Updated April 15, 2015